...
首页> 外文期刊>Medicinal chemistry >A Novel Method to Synthesize Phosphocreatine and Phosphocreatine Prodrugs
【24h】

A Novel Method to Synthesize Phosphocreatine and Phosphocreatine Prodrugs

机译:一种合成磷酸磷和磷酸甲虫前药的新方法

获取原文
获取原文并翻译 | 示例

摘要

Background: Adenosine triphosphate (ATP) is the energy currency of the body; it takespart in various and indispensable metabolic processes for the maintenance of cell homeostasis, degradingto its hydrolysis product, adenosine diphosphate (ADP). Efficient ways to restore ATP aretherefore necessary in the cells. When the cell lacks energy due to ischemic conditions or highATP demand, phosphocreatine gives its phosphate group to ADP that converts to ATP, in a reactioncatalyzed by the enzyme creatine kinase. For this reason, phosphocreatine is utilized as apharmacological treatment in human diseases that involve a failure of the cellular energy, most notablyin coronary artery disease.Objective: Commercially available phosphocreatine is currently synthesized using different methods,each of one characterized by a rather low yield of the final product, probably due to the lowreactivity of the guanylating reagent. The aim of this work is to overcome the drawbacks of thesynthetic methods currently employed, devising a novel synthetic route to obtain phosphocreatineand phosphocreatine prodrugs in higher yields and purity.Method: To obtain a higher yield of the final product and a lower number of sub-products, thismethod utilizes a new guanylating agent characterized by high reactivity, endowed with a protectinggroup t-Boc on one of the two nitrogen atoms of the guanidinic function and a protected phosphateon the other one; that compound is then conjugated with an opportune secondary amine. Theobtained product is cleaved first with acidic conditions to obtain the phosphocreatine prodrug(phosphocreatine ethyl ester) and then with an enzymatic method to obtain the phosphocreatine.Result: Have been obtained in good yield and purity as demonstrated by HPLC and mass spectrometryanalysis.Conclusion: This novel synthetic route permits to obtain the phosphocreatine molecule in higheryield and purity compared to the methods currently employed with a combination of chemical andenzymatic methods.
机译:背景:腺苷三磷酸(ATP)是身体的能量货币;它突布了各种和不可或缺的代谢过程,用于维持细胞稳态,降解其水解产物,腺苷二磷酸(ADP)。在细胞中需要有效的恢复ATP的方法。当细胞由于缺血性条件或高度要求而缺乏能量时,磷酸氨基氨基将其磷酸盐基团赋予ADP,其转化为ATP,在由酶肌酸激酶的反应催化剂中转化为ATP。出于这个原因,磷酸氨基被用作人类疾病中的APHMACACACACACACTICAL治疗,所述人类疾病涉及细胞能量的失败,最易用的冠状动脉疾病。目前使用不同方法合成商业上可获得的磷酸氨基,其次是一种相当低的产量最终产品,可能是由于致胍化试剂的低反应性。这项工作的目的是克服目前使用的对合成方法的缺点,设计了一种新的合成途径,以获得更高产率和纯度的磷酸甲基磷酸氨基前药物。方法:获得最终产品的更高产量和较少数量的子产物,该方法利用具有高反应性的新的致胶质化剂,赋予胍杂种功能的两个氮原子之一的保护群T-Boc,另一个亚硝基原子中的一个;然后将该化合物与合适的仲胺缀合。首先用酸性条件切割酸性产物,得到磷酸氨基吡啶(磷酸乙酯),然后用酶促方法获得磷酸官。结果:通过HPLC和质谱分解证明的良好产量和纯度获得。结论:这与目前用化学和酶方法的组合使用的方法相比,新颖的合成途径允许在Higheryield和纯度中获得磷酸分子分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号